---
title: "Bridging across NGS-based Olink^®^ products"
output:
rmarkdown::html_vignette:
toc: true
toc_depth: 3
fig_caption: TRUE
includes:
in_header: ../man/figures/logo.html
vignette: >
%\VignetteIndexEntry{Bridging across NGS-based Olink products}
%\VignetteEncoding{UTF-8}
%\VignetteEngine{knitr::rmarkdown}
date: 'Compiled: `r format(Sys.Date(), "%B %d, %Y")`'
editor_options:
markdown:
wrap: 72
---
```{r, include = FALSE}
knitr::opts_chunk$set(
collapse = TRUE,
comment = "#>",
tidy = FALSE,
tidy.opts = list(width.cutoff = 95),
fig.width = 6,
fig.height = 3,
message = FALSE,
warning = FALSE,
time_it = TRUE,
fig.align = "center"
)
```
```{r, echo=FALSE, eval = TRUE}
library(OlinkAnalyze)
library(dplyr)
library(stringr)
library(ggplot2)
library(kableExtra)
```
## Introduction
Individual Olink^®^ NPX^TM^ projects are generally normalized using
either plate control normalization or intensity normalization methods.
Since NPX is a relative measurement, in the case when a study is
separated into multiple projects, an additional normalization step is
needed to allow the data to be comparable across projects. The following tutorial is
designed to give you an overview of the Olink bridging procedure for
combining data sets from Olink^®^ Explore 3072, Olink^®^ Explore HT,
and Olink^®^ Reveal products.
### Important Terminology
- **Bridging samples** – Overlapping samples run on two or more projects
that are used as references to enable normalization. These
samples are selected as described in the [Introduction to Bridging
tutorial](bridging_introduction.html)
to ensure samples are of high quality and span the range of the
data. In the case of data containing LOD, samples are also filtered
for high detectability. Bridging samples are selected from the project
that is run first to run with the second project.
- **Project** – A set of plates that run at the same time and have been normalized together. If two projects are not randomized or are run at different times then additional normalization is required.
- **Project effect/correction** – As NPX is a relative quantification,
overall NPX values may shift across projects. This can result in
separation of projects that are part of the same study which can be
corrected for using normalization or accounted for within a
statistical model.
- **Within-product bridging** – Normalization of two or more projects
run on the same Olink product using bridging samples
- **Between-product bridging** - Normalization of two or more projects
from different Olink products (in this case, Olink Explore 3072 and
Olink Explore HT) using bridging samples
- **Reference data** – The project data which is being normalized to
is known as the reference data. In the case of between-product
bridging, the reference project is the Explore HT NPX data or Reveal NPX data. The
reference data set is not altered during bridging and the other data
set is adjusted to the reference data set using the bridging samples.
### Within- and between-product bridging
The joint analysis of two or more NPX projects run on the same Olink
product often requires a project correction step to remove
technical variation. One such method of normalizing two projects is referred to as bridge sample reference
normalization, bridge normalization, or just simply bridging. For more
information on within-product bridging, see the [Introduction to
Bridging
tutorial](bridging_introduction.html).
Bridging makes certain assumptions on the distributions of
the assays, namely that we are measuring the same true biological range
no matter the setting. If an assay displays different distributions
between projects, then both bridging and downstream statistical
analysis will be affected. Within a product, we assume the variance and
shape of the distribution remains constant within assays.
In the case where a study consists of separate projects run on Olink
Explore 3072 and either Olink Explore HT or Olink Reveal, an additional project correction step
is required to allow data from these two products to be analyzed
together, which is referred to as between-product bridging. Olink Explore 3072, Olink Explore HT, and Olink Reveal are all products that use PEA technology combined with next
generation sequencing to calculate NPX for thousands of proteins.
However, assays may vary more between products then within a product, and fewer assumptions
can be made regarding the similarity of assay distributions and
variance between products.
Since many of the assays profiled in Olink Explore 3072 are also found
on Olink Explore HT or Olink Reveal, bridging data across products enables increased
power in studies consisting of data from multiple Olink products, rather than limiting these studies to meta-analysis. However, differences between products, such as the
number of assays being measured and the reagents being used, can sometimes lead to signal in one product and noise in
another product. Bridging signal to noise can have detrimental effects
on downstream statistical analysis. This means that while some assays
will be able to be bridged using the same method as in within-product
bridging, others will require a different normalization method, and some
will not be bridgeable at all. This normalization strategy combines
median-centering (as is used in within-product bridging) and quantile
smoothing to normalize assays across products based on the assumption
that assays can be bridged provided they have signal in both products or
noise in both products.
### Considerations for between-product bridging
Product bridging allows the NPX values of an Olink Explore 3072 project
to be normalized and made comparable to the NPX values of an Olink
Explore HT project or an Olink Reveal project. This process is one-directional, and normalizing
Olink Explore HT NPX values or Olink Reveal NPX values to Olink Explore 3072 is not supported. Normalization between Olink Explore HT and Olink Reveal in either direction are also not supported.
The product bridging normalization uses the assays that are
overlapping between the two products. ~2900 assays overlap between Olink Explore HT and Olink Explore 3072 and ~850 assays overlap between Olink Reveal and Olink Explore 3072. Each
overlapping assay undergoes a series of checks that evaluate the number
of counts, correlation, and difference of NPX ranges between the two
data sets. If an assay has enough counts and comparable metrics between
the two data sets, it is determined to be suitable for bridging
(referred to as a "bridgeable assay"). Assays that are not suitable for bridging can either be excluded from downstream analysis in one or both products or results can be integrated across products using meta-analysis. The set of bridgeable assays
across products will vary from data set to data set, based on the
samples present within the studies. Depending on the NPX distribution of
each bridgeable assay in the two data sets, the assay is normalized
using either median normalization or quantile smoothing.
Bridging an Explore 3072 data set to an Explore HT NPX data set
requires 40 - 64 bridging samples, while bridging an Olink Explore 3072 data set to an Olink Reveal data set requires 32-48 bridging samples. Bridging samples are shared samples
among data sets and, as such, are analyzed in both data sets. Olink NPX
data sets without shared samples cannot be combined using the
bridging approach described below. More information on bridge sample
selection can be found in the [selecting bridging samples
section](bridging_introduction.html#selecting-bridging-samples)
of the Introduction to Bridging tutorial.
## Bridge Sample Selection
Prior to running a study with Explore HT or Olink Reveal, bridging samples must be selected
from the study run with Explore 3072 and be run on the subsequent study. These samples can
be selected using the `olink_bridgeselector()` function in Olink Analyze
as detailed in [the Introduction to bridging
tutorial](bridging_introduction.html#selecting-bridging-samples). The recommended number of bridge samples for within- and between- product bridging is summarized in the table below. When selecting bridge samples, the aim is to select samples that represent the dynamic range of the assay expression in the product. As such, quality control of the sample and, if available, proportion of data above LOD in the sample are considered when determining if a sample is chosen as a bridging sample. When LOD data is not available in the data export from Olink NPX software, LOD can optionally be calculated from fixed LOD or negative controls as
detailed in the [Calculating LOD from Olink Explore data
tutorial](LOD.html).
```{r brnrtab, eval=TRUE, message=FALSE, echo = FALSE}
data.frame(Platform = c("Target 96",
paste0("Explore 384: \n",
"Cardiometabolic, Inflammation, ",
"Neurology, and Oncology"),
paste0("Explore 384: \n",
"Cardiometabolic II, Inflammation II,",
"Neurology II, and Oncology II"),
"Explore HT",
"Explore 3072 to Explore HT",
"Explore 3072 to Reveal"),
BridgingSamples = c("8-16",
"8-16",
"16-24",
"16-32",
"40-64",
"32-48")) |>
kbl(booktabs = TRUE,
digits = 2,
caption = "Recommended number of bridging samples for Olink platforms") |>
kable_styling(bootstrap_options = "striped",
full_width = FALSE,
position = "center",
latex_options = "HOLD_position")
```
## Workflow Overview
Olink Explore 3072 to Olink Explore HT bridging requires Explore 3072
data and Explore HT data which have at least 40 to 64 bridging samples.
Olink Explore 3072 to Olink Reveal bridging requires Explore 3072
data and Reveal data which have at least 32 to 48 bridging samples. For
studies containing multiple projects of Explore 3072 data, the Explore
3072 data sets should be bridged using within-product bridging as
detailed in the [Introduction to bridging
tutorial](bridging_introduction.html) or otherwise normalized together
prior to performing between-product bridging.
The assays from Explore 3072 are matched to the corresponding assays in
Explore HT or Reveal and evaluated to determine if the assay is bridgeable. Additionally, all assays are normalized using both quantile smoothing and
normalization using the median of paired differences. The result is an
adjusted Explore 3072 data set with five additional columns. Three of these columns relate to bridging normalization:
- `BridgingRecommendation`: a flag which indicates if the assay is
bridgeable and, if so, which normalization method is recommended
- `MedianCenteredNPX`: NPX values after normalization using the median
of paired differences
- `QSNormalizedNPX`: NPX values after normalization using quantile
smoothing
Data from Explore 3072 and the reference product (Explore HT or Reveal) will be concatenated in the function export. Two additional columns are added to aid in data mapping and export.
- `Project`: the name of the project as define in the function input
- `OlinkID_E3072`: mapped Olink IDs from Explore 3072. Olink IDs from Explore HT or Reveal will be listed in the `OlinkID` column.
Note that regardless of the bridging recommendation, NPX values will be
available for both normalization methods. A visual representation of the between-product bridging workflow is shown below.
```{r, fig.cap= fcap, eval = TRUE, echo = FALSE, out.width="50%"}
knitr::include_graphics(normalizePath("../man/figures/Bridging_schematic.png"),
error = FALSE)
fcap <- "Schematic of Between-Product Bridging Workflow"
```
## Import NPX files
To normalize Explore 3072 data to Explore HT or Reveal data, first the two data
sets are read into R using `read_NPX()`. If more than two data sets are
being normalized, all Explore 3072 studies should be normalized together
prior to normalizing between products and the concatenated bridged data
set should be used as the input. In the case of multiple Explore HT
studies or multiple Reveal studies, only one study should be chosen as the reference
data set. The data can be loaded using `read_NPX()` function with
default Olink Software NPX file as input, as shown below.
```{r message=FALSE, eval=FALSE, echo = TRUE}
# Note: Explore 3072 and Reveal files can be CSV or parquet.
data_explore3072 <- read_NPX("~/NPX_Explore3072_location.parquet")
data_reference_product <- read_NPX("~/NPX_ExploreHT_location.parquet")
# Or for reveal data
data_reference_product <- read_NPX("~/NPX_Reveal_location.parquet")
```
## Checking input datasets and bridging samples
First, confirm that there are overlapping sample IDs within the study. Note that external controls should not be included in the list of
bridging samples, as detailed in the [Bridge Sample Selection] section
of this tutorial. External control samples often share the same naming
convention across data sets but may represent different samples due to
reagent batch differences. Appending the project name to the end of the
control samples can ensure unique Sample IDs. For the example below Explore HT data is used as the reference project, however the sample process can performed using Reveal as the reference data.
```{r, echo=TRUE, eval = FALSE}
data_explore3072_samples <- data_explore3072 |>
dplyr::filter(SampleType == "SAMPLE") |>
dplyr::distinct(SampleID) |>
dplyr::pull()
data_reference_product_samples <- data_reference_product |>
dplyr::filter(SampleType == "SAMPLE") |>
dplyr::distinct(SampleID) |>
dplyr::pull()
overlapping_samples <- unique(intersect(data_explore3072_samples,
data_reference_product_samples))
# Note that if `SampleType` is not is input data:
# stringr::str_detect can be used to exclude control samples based on SampleID.
```
```{r echo=FALSE}
try(
readRDS(normalizePath("../man/figures/overlapping_samples_table.rds")) |>
kableExtra::kbl(booktabs = TRUE,
digits = 2,
caption = "Overlapping bridging samples") |>
kableExtra::kable_styling(bootstrap_options = "striped",
full_width = FALSE,
position = "center",
latex_options = "HOLD_position")
)
```
PCA plots for each dataset can be used to assess if any bridge samples are outliers in the dataset.
```{r include=FALSE}
f3 <- paste0("PCA plot prior to bridging for Explore 3072 data",
" and data from the reference product.",
" Bridge samples are indicated by color.",
" PCA plots can be helpful in assessing",
" if any bridge samples were outliers in one of the platforms.")
```
```{r eval = FALSE}
#### Extract bridging samples
data_explore3072_before_br <- data_explore3072 |>
dplyr::filter(SampleType == "SAMPLE") |>
# Note that if `SampleType` is not is input data,
# stringr::str_detect can be used to exclude control samples
# based on naming convention.
dplyr::mutate(Type = if_else(SampleID %in% overlapping_samples,
paste0("Explore 3072 Bridge"),
paste0("Explore 3072 Sample")))
data_reference_product_before_br <- data_reference_product |>
dplyr::filter(SampleType == "SAMPLE") |>
dplyr::mutate(Type = if_else(SampleID %in% overlapping_samples,
paste0("Reference Product Bridge"),
paste0("Reference Product Sample")))
### PCA plot
pca_E3072 <- OlinkAnalyze::olink_pca_plot(df = data_explore3072_before_br,
color_g = "Type",
quiet = TRUE)
pca_EHT <- OlinkAnalyze::olink_pca_plot(df = data_reference_product_before_br,
color_g = "Type",
quiet = TRUE)
```
```{r echo=FALSE, fig.cap=f3, fig.height= 8, fig.width= 6}
knitr::include_graphics(normalizePath("../man/figures/PCA_btw_product_before.png"),
error = FALSE)
```
## Normalization
The `olink_normalization()` functionality has been expanded and can be used
to determine which assays are bridgeable and of the bridgeable assays what
normalization method is advised, and to calculate normalized NPX values
for the Explore 3072 (non-reference) project. Normalized NPX values are calculated for
all assays across products as described in the [Workflow Overview] and in
the sections below. Within this function, the bridging recommendations
for each assay are determined and the NPX values are normalized using
the two methods described below.
The `olink_normalization()` function contains a format argument that is set to
'FALSE' by default. This will export the dataframe with the format shown in Table 4 of the
[Function Output] section. The values in the NPX column will remain unchanged and
median-centered NPX values and QS-normalized NPX values will be populated in the
`MedianCenteredNPX` and `QSNormalizedNPX` columns for all datapoints,
regardless of bridging recommendation.
If the format argument is set to `TRUE`, this will export the dataframe with the
NPX values replaced with the bridged NPX values corresponding to the bridging recommendation
(see Table 5 of the [Function Output] section). For more information, see the [Downstream Analysis] section below.
```{r eval = FALSE}
# Find shared samples
npx_ht <- data_reference_product |>
dplyr::mutate(Project = "data1")
npx_3072 <- data_explore3072 |>
dplyr::mutate(Project = "data2")
# perform between-product bridging without formatting for downstream analysis
npx_br_data <- olink_normalization(df1 = npx_ref_product,
df2 = npx_3072,
overlapping_samples_df1 =
overlapping_samples,
df1_project_nr = "Reference Product",
df2_project_nr = "Explore 3072",
reference_project = "Reference Product",
format = FALSE)
# perform between-product bridging with formatting for downstream analysis
npx_br_data <- olink_normalization(df1 = npx_ref_product,
df2 = npx_3072,
overlapping_samples_df1 =
overlapping_samples,
df1_project_nr = "Reference Product",
df2_project_nr = "Explore 3072",
reference_project = "Reference Product",
format = TRUE)
```
### Determining bridging recommendations
For an assay to be bridgeable across products, it must either have signal
in both products or be primarily background signal in both products.
Bridging noise into signal or signal into noise can negatively impact
downstream statistical analysis. To determine if an assay is bridgeable,
the bridge samples from both products are used to assess the following
criteria:
- Is there a linear relationship between products?
- **Assessing linearity across products:** To determine if there
is a linear relationship between products for an assay, the
linear coefficient of determination (R^2^) is calculated using
Pearson correlation. R^2^ is a measure of how much of the
variation in the data is explained by the linear function
compared to just using the mean. In this correlation, counts
below 10 are excluded due to lack of signal. The R^2^ value is
calculated and an assay is considered to have a linear
relationship across products if the R^2^ value is above the
cutoff. A higher R^2^ value indicates, that for both products,
the assay is in the linear range. Conversely, a low R^2^ means
that either one or both assays are in background. The default
cutoff is set to R^2^ \> 0.8 indicating that at least 80% of the
variation in the data is explained by the linear function.
- Are the NPX ranges in the two products similar?
- **Assessing similarity of NPX ranges:** To determine if the NPX
ranges are similar across products, the difference in NPX values
from the 10% to 90% quantile is calculated for each product,
excluding data points with counts less than 10. If the
difference in range of NPX between products is greater than the
cutoff then the ranges are not considered similar across
products. Since the NPX values are calculated on the same
samples, it is expected that an increase in 1 NPX in one product
would correspond to an increase of 1 NPX in the other product.
If the ranges are not similar, this suggests that 1 NPX is not
equivalent across products. By default, the cutoff is set to a
difference of less than 1 NPX between products.
- Are there sufficient counts in both products?
- **Assessing if there are sufficient counts:** An assay's
absolute level of counts is important to consider as the
instruments used to generate NPX values have an inherent noise
level. To determine if there are sufficient counts in an assay
for bridging, the median number of counts in both products is
calculated, excluding data points with less than 10 counts. If
the median number of counts is less than the cutoff then the
assay does not have sufficient counts to be used for bridging.
The default cutoff is set to 150 counts, which is based on the
count quality control metrics for Explore products.
For assays that are bridgeable, the shape of the NPX distribution is
compared between the two products:
- **Assessing similarity of NPX distribution across products:** If the
three criteria outlined above are met then the assay is considered
bridgeable. Otherwise, bridging is not recommended for that assay.
If an assay is bridgeable, the similarity of the NPX distribution is
used to determine which method is recommended for bridging. The
Kolmogorov-Smirnov test, or KS test, is used to assess the
similarity of two distributions by calculating the KS statistic,
which is based on the empirical cumulative distribution function
(ECDF). Counts below 10 are excluded and the largest difference seen
in the ECDF becomes the KS statistic. If the KS statistic is above
the cutoff, the distributions are considered to have different
shapes. In this case, a median shift is not sufficient to normalize
the data, and quantile smoothing is recommended. If the distance is
less than the cutoff, then normalization using the median of paired
differences is recommended. By default this cutoff difference is set
to 0.2.
An overview of these criteria is visualized below.
```{r echo=FALSE, fig.cap=fcap, out.width="50%"}
knitr::include_graphics(normalizePath("../man/figures/assay_bridgeability.jpg"),
error = FALSE)
fcap <- paste("Criteria to determine the bridging recommendation for an assay.",
"The assessment of linearity ensures bridging between signal in both platforms",
"or noise in both platforms (but not between signal and noise).",
"Similar NPX ranges and sufficient counts provide additional insight into",
"an assay's bridgeability.",
"Distribution shape is assessed to determine recommended bridging method.",
sep = " ")
```
\
\
The olink_bridgeability_plot function generates a series of figures on a per-assay
basis for a dataframe generated from between-product bridging, based on the bridging
samples used in the bridge normalization. The coloration of the figure headers indicate
whether that assay has been defined as bridgeable or not bridgeable. Red headers
indicate that an assay is not bridgeable and blue headers indicate that a
an assay is bridgeable. The correlation plot, violin plot, and bar chart figures illustrate
the three criteria described above for determining whether an assay is bridgeable.
If an assay is determined to be bridgeable, the ECDF curve and corresponding KS statistic
are used to determine which normalization approach (median centering or quantile smoothing)
is most suitable for between-product normalization.
```{r eval = FALSE}
# generating olink_bridgeability_plot figures
npx_br_data_bridgeable_plt <- olink_bridgeability_plot(
data = npx_br_data,
median_counts_threshold = 150,
min_count = 10,
bridge_sampleid = overlapping_samples
)
npx_br_data_bridgeable_plt[[1]]
```
```{r message=FALSE, echo = FALSE, out.width = "675px", fig.cap = fcap}
knitr::include_graphics(normalizePath("../man/figures/bridgeable_plt_MedianCenter.png"), error = FALSE)
fcap <- "Visualization of an assay's bridgeability criteria as generated by the olink_bridgeability_plot function."
```
\
\
Prior to assessment, outlier bridging samples are excluded. A sample is
considered an outlier if the NPX value is more than 3 times the
interquartile range above or below the median on either product.
After assessment, an assay is considered bridgeable if it meets the
first three criteria. The fourth criteria determines which normalization
method is recommended for bridging. If all four criteria are met then
the recommended method is normalization using the median of paired
differences. If only the first three criteria are met then quantile
smoothing is recommended. If any of the first three criteria are not met
then bridging is not recommended for that assay. Note that bridgeable
assays will differ between projects based on the expression of bridge
samples in the studies.
### Normalization using the median of paired differences
If it is expected that both the kind of distribution and the variance
per test between runs are the same, then normalization using the median
of paired differences will be preferred. Normalization using the median
of paired differences based on the bridging samples is performed in the
following steps:
1. For each assay in the Explore 3072 project, the pairwise difference
is calculated for each of the bridging samples with the Explore HT or Reveal
project.
2. The normalization factor is estimated for each assay by finding the
median of the pairwise differences.
3. The assay-specific normalization factor for each assay is used to
normalize each data point from Explore 3072 to Explore HT or Reveal.
### Quantile smoothing
Since Explore HT and Explore 3072 are two distinct products with
different workflows involved in generating NPX data, some of the assays
exist in corresponding but distinct NPX spaces. For those assays, the
median of paired differences is insufficient for bridging as it only
considers one anchor point (the median/50% quantile). Instead, quantile
smoothing (QS) using multiple anchor points (5%, 10%, 25%, 50%, 75%, 90%
and 95% quantiles) is favored to map the Explore 3072 data to the
Explore HT or Reveal distribution. The normalization using QS uses bridging samples
to perform the following steps:
1. Each data point of the samples from Explore 3072 is mapped to the
equivalent space in the reference product using an empirical cumulative
distribution function. An empirical cumulative distribution function
is a probability model which uses the observed data, in this case
the NPX values of the bridging samples for an assay, to create a step
function which interpolates linearly between the available data
points.
2. The empirical distribution function is used to map the data points
from Explore 3072 to the reference product space using the specified
quantiles. At this point all data points from the bridging samples
have NPX values that are normalized to the data points in the reference
product.
3. To normalize the remaining data, a spline regression model is
constructed using the sorted Explore 3072 data (prior to mapping) and the mapped
Explore 3072 data, along with the anchor points of the spline
function. A spline regression model divides a data set at the
quantiles and uses the quantile as an anchor point or knot. Then a
model is generated to fit the points between each anchor point.
4. The spline regression model is then used to predict all the data
points from Explore 3072 to the reference product.
The spline regression model
results in a combination of linear regression models within
intervals. The Explore 3072 NPX values are input as the x value
within the corresponding interval, which results in a y value
equivalent to the reference product NPX value.
### Function Output
The output from `olink_normalization()` function when used for between
product bridging is a dataframe with concatenated data from the two products
and additional columns including adjusted NPX values, bridging recommendations,
mapping information, and project names. The adjusted NPX values are notated in
the columns `MedianCenteredNPX` and `QSNormalizedNPX`. For each assay a
recommendation is listed in the `BridgingRecommendation` column and
lists what method, if any should be used for that assay. Additional
columns including `OlinkID` and `OlinkID_E3072` map the assays across
products and the `Project` column lists the name of the project based on
the `df1_project_nr` and `df2_project_nr` arguments. The resulting
data set will contain the newly bridged Explore 3072 data set. The
reference product data will be concatenated to the Explore 3072 data.
As the reference data is not altered during normalization, the
normalized NPX values in the Explore HT or Reveal data will be the same as the
values in the NPX column which contains the non-normalized data.
```{r echo=FALSE}
try(
readRDS(normalizePath("../man/figures/bridging_results.rds")) |>
kableExtra::kbl(booktabs = TRUE,
digits = 1,
caption = "Table 4. First 5 rows of combined datasets after bridging with between-product formatting argument set to FALSE.") |>
kableExtra::kable_styling(bootstrap_options = "striped", full_width = FALSE, font_size = 10,
position = "center", latex_options = "HOLD_position") |>
kableExtra::scroll_box(width = "100%")
)
```
```{r echo=FALSE}
try(
readRDS(normalizePath("../man/figures/bridging_results.rds")) |>
dplyr::mutate(NPX = case_when(
BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
.default = NPX)) |>
dplyr::mutate(SampleID = paste(SampleID, Project, sep = "_")) |>
dplyr::mutate(OlinkID = ifelse(!(BridgingRecommendation == "NotBridgeable"),
paste(OlinkID, OlinkID_E3072, sep = "_"),
OlinkID_E3072)) |>
dplyr::select(-c("OlinkID_E3072", "MedianCenteredNPX", "QSNormalizedNPX")) |>
kableExtra::kbl(booktabs = TRUE,
digits = 1,
caption = "Table 5. First 5 rows of combined datasets after bridging with between-product formatting argument set to TRUE.") |>
kableExtra::kable_styling(bootstrap_options = "striped", full_width = FALSE, font_size = 10,
position = "center", latex_options = "HOLD_position") |>
kableExtra::scroll_box(width = "100%")
)
```
## Evaluating the quality of bridging
PCA is used to assess the quality of bridging by determining if the
sample controls (SCs) and bridging samples appear closer after bridging.
Two PCAs can be generated, one containing the SCs and one containing the
bridging samples. Prior to bridging there will be a noticeable
separation between products which should decrease after bridging.
```{r include=FALSE}
f8 <- "Combined PCA of sample controls from both platforms prior to normalization."
f9 <- "Combined PCA of bridging samples from both platforms prior to normalization."
f10 <- "Combined PCA of sample controls from both platforms after normalization."
f11 <- "Combined PCA of bridging samples from both platforms after normalization."
```
```{r pca_pre_sc, echo=TRUE, eval = FALSE}
## Before Bridging
npx_br_data |>
dplyr::filter(SampleType == "SAMPLE_CONTROL") |>
dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072)) |>
dplyr:::mutate(SampleID = paste0(Project, SampleID)) |>
OlinkAnalyze::olink_pca_plot(color_g = "Project")
```
```{r pca_pre_sc_fig, echo=FALSE, fig.cap=f8, message=FALSE}
## Before Bridging
knitr::include_graphics(normalizePath("../man/figures/SCs_pre_bridging.png"),
error = FALSE)
```
```{r pca_pre_bridge, echo=TRUE, eval=FALSE}
## Before Bridging
npx_br_data |>
dplyr::filter(SampleType == "SAMPLE") |>
dplyr::filter(SampleID %in% overlapping_samples) |>
dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072)) |>
dplyr:::mutate(SampleID = paste0(Project, SampleID)) |>
OlinkAnalyze::olink_pca_plot(color_g = "Project")
```
```{r echo=FALSE, fig.cap=f9}
knitr::include_graphics(normalizePath("../man/figures/bridges_pre_bridging.png"),
error = FALSE)
```
```{r eval = FALSE}
## After bridging PCA
### Keep the data following BridgingRecommendation
npx_after_br_reco <- npx_br_data |>
dplyr::filter(BridgingRecommendation != "NotBridgeable") |>
dplyr::mutate(NPX = case_when(
BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
.default = NPX)) |>
dplyr::filter(AssayType == "assay") |>
dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072))
```
``` {r pca_post_SC, eval=FALSE, echo = TRUE}
### Generate unique SampleIDs
npx_after_br_final <- npx_after_br_reco |>
dplyr:::mutate(SampleID = paste0(Project, SampleID))
### PCA plot of the data from SCs
npx_after_br_final |>
dplyr::filter(SampleType == "SAMPLE_CONTROL") |>
OlinkAnalyze::olink_pca_plot(color_g = "Project")
```
```{r echo=FALSE, fig.cap=f10}
knitr::include_graphics(normalizePath("../man/figures/SCs_post_bridging.png"),
error = FALSE)
```
```{r echo=TRUE, eval = FALSE}
### PCA plot of the data from bridging samples
npx_after_br_reco |>
dplyr::filter(SampleType == "SAMPLE") |>
dplyr::filter(SampleID %in% overlapping_samples) |>
dplyr:::mutate(SampleID = paste0(Project, SampleID)) |>
OlinkAnalyze::olink_pca_plot(color_g = "Project")
```
```{r echo=FALSE, fig.cap=f11}
knitr::include_graphics(normalizePath("../man/figures/bridges_post_bridging.png"),
error = FALSE)
```
## Exporting Normalized Data
The normalized Explore 3072 data can be exported using
`arrow::write_parquet()` to create a long format Olink Explore file.
```{r eval = FALSE}
df <- npx_br_data |>
dplyr::filter(Project == "Explore_3072") |>
arrow::as_arrow_table()
df$metadata$FileVersion <- "NA"
df$metadata$ExploreVersion <- "NA"
df$metadata$ProjectName <- "NA"
df$metadata$SampleMatrix <- "NA"
df$metadata$DataFileType <- "Olink Analyze Export File"
df$metadata$ProductType <- "Explore3072"
df$metadata$Product <- "Explore3072"
arrow::write_parquet(x = df, sink = "path_to_output.parquet")
```
## FAQs
### Overlapping Assays within products
Both the Explore 3072 and Explore HT products contain assays that appear
multiple times in the product, known as overlapping assays or
correlation assays. In Explore 3072, these present as overlapping assays
across panels. In Explore HT, these are overlapping assays across
blocks. These assays are included for QC purposes and allow users to
evaluate data performance across panels in Explore 3072 and across
blocks in Explore HT. Within each product, the assays contain unique OlinkID values for each of their corresponding panels and blocks in Explore 3072 and Explore HT,
respectively.
IL6, IL8 (CXCL8), and TNF are included in the
Cardiometabolic, Oncology, Neurology and Inflammation panels, while
IDO1, LMOD1, and SCRIB are included in the Cardiometabolic II, Oncology
II, Neurology II and Inflammation II panels. Each correlation assay is
measured four times in an Olink Explore 3072 run. In Explore HT, GBP1
and MAPK1 serve as overlapping assays and are measured three times in a
run.
### Downstream Analysis
Olink Analyze statistical analysis functions default to use the data in
the `NPX` column. To use the recommended normalized data, set the `olink_normalization()`
format argument to `TRUE` when performing bridge normalization. The `NPX` column values
will be replaced with the recommended normalized values corresponding to the normalization
approach identified in the `BridgingRecommendation` column. Datapoints identified as `NotBridgeable`
will retain their original NPX values and OlinkIDs. Assays that are not overlapping between
products will be identified as "NotOverlapping" and will retain their original NPX values and OlinkIDs.
External controls will be removed from the formatted dataframe. Sample IDs will be concatenated
with their corresponding project IDs to ensure that all samples are analyzed individually.
Additionally, to ensure that overlapping assays within products are analyzed individually,
OlinkID can be temporarily assigned to the concatenated version of the OlinkIDs in the bridgeable assays.
The `OlinkID_E3072`, `MedianCenteredNPX`, and `QSNormalizedNPX` columns will be removed.
This dataframe can then be used in any downstream analysis function within Olink Analyze.
It should be noted that the format argument in the `olink_normalization()` only applies to
between-product bridgings and modifying this argument for within-product bridgings will
not affect the output format of the resulting dataframe.
Alternatively, if the `olink_normalization()` function is run with the format argument set to 'FALSE',
then the `NPX` column will not be modified and the non-normalized NPX data will be used by default.
To use the recommended normalized data, dplyr::mutate() can be used to reassign the NPX data.
Additionally, to ensure that overlapping assays within products are analyzed individually,
OlinkID can be temporarily assigned to the concatenated version of the OlinkIDs. This dataframe can then
be used in any downstream analysis function within Olink Analyze.
Assays which are not recommended for bridging should be analyzed separately and can be combined using a
meta-analysis. Depending on the study design these assays can either be excluded from the downstream analysis
or the assays can be treated as non-overlapping assays.
```{r echo=TRUE, eval=FALSE}
# npx_after_br_final generated by olink_normalization with format = TRUE
# Option 1: Exclude non-bridgeable assays from both products
npx_recommended <- npx_br_data |>
dplyr::filter(BridgingRecommendation != "NotBridgeable") |>
# Option 2: Analyze non-bridgeable assays separately
# No further preprocessing needed
npx_recommended <- npx_br_data
# npx_after_br_final generated by olink_normalization with format = FALSE
# Option 1: Exclude non-bridgeable assays from both products
npx_recommended <- npx_br_data |>
dplyr::mutate(NPX_original = NPX) |>
dplyr::filter(BridgingRecommendation != "Not Bridgeable") |>
dplyr::mutate(NPX = case_when(
BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
.default = NPX)) |>
dplyr::mutate(OlinkID_HT = OlinkID) |>
dplyr::mutate(OlinkID = paste0(OlinkID, "_", OlinkID_E3072))
# Option 2: Analyze non bridgeable assays separately
npx_recommended <- npx_br_data |>
dplyr::mutate(NPX_original = NPX) |>
dplyr::mutate(NPX = case_when(
BridgingRecommendation == "MedianCentering" ~ MedianCenteredNPX,
BridgingRecommendation == "QuantileSmoothing" ~ QSNormalizedNPX,
.default = NPX)) |>
dplyr::mutate(OlinkID_HT = OlinkID) |>
dplyr::mutate(OlinkID = ifelse(BridgingRecommendation != "NotBridgeable",
paste0(OlinkID, "_", OlinkID_E3072),
# Concatenated OlinkID for bridgeable Assays
ifelse(Project == "Reference Product",
# replace with reference project name as set in function
OlinkID,
OlinkID_E3072)))
```
## Contact Us
We are always happy to help. Email us with any questions:
- biostat\@olink.com for statistical services and general stats
questions
- support\@olink.com for Olink lab product and technical support
- info\@olink.com for more information
## Legal Disclaimer
© 2025 Olink Proteomics AB, part of Thermo Fisher Scientific.
Olink products and services are For Research Use Only. Not for use in diagnostic procedures.
All information in this document is subject to change without notice. This document is not intended to convey any warranties, representations and/or recommendations of any kind, unless such warranties, representations and/or recommendations are explicitly stated.
Olink assumes no liability arising from a prospective reader’s actions based on this document.
OLINK, NPX, PEA, PROXIMITY EXTENSION, INSIGHT and the Olink logotype are trademarks registered, or pending registration, by Olink Proteomics AB. All third-party trademarks are the property of their respective owners.
Olink products and assay methods are covered by several patents and patent applications [https://www.olink.com/patents/](https://olink.com/patents/).